Search
for
Sort by
Research 361–390 of 1000+
- Efficacy of Oral Supplementation with Serenoa Repens, Pumpkin Seed Extract and Cysteine Combined with Topical Minoxidil 5% Vs Topical Minoxidil 5% Alone in Androgenic Alopecia A Randomised Assessor-Blinded 6-Month, Superiority Trial
- Risk factors and lipid metabolism characteristics of early‐onset male androgenetic alopecia: A pilot study
- Androgenetic alopecia and metabolic syndrome: A cross-sectional study in Northeast India
- Efficacy of Platelet-Rich Plasma in Males With Androgenetic Alopecia
- The “NOMINAL” trial: Clinical efficacy, cosmetic acceptability, and local tolerability of topical 5% minoxidil lotion without propylene glycol: A 6-month, multicentre, real-life, prospective, assessor-blinded study in 196 subjects with hair loss.
- Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial
- Therapeutic-effects-of-growth-factor-cocktail-including-fibroblast-growth-factor-9-in-patients-with-androgenetic-alopecia-a-split-study
- Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments
- Comparative Study of a Topical and Oral Combination Therapy Containing Oleanolic Acid, Apigenin, and Biotinyl Tripeptide-1 in Patients with Androgenetic Alopecia: A Prospective, Open-Label Trial
- The Association of Serum Adipokines, Insulin Resistance and Vitamin D Status in Male Patients with Androgenetic Alopecia
- Mesenchymal Stromal Cell-Conditioned Medium for Skin Diseases: A Systematic Review
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- From Diagnosis to Prognosis: A Scoping Review of Artificial Intelligence in Alopecia Research
- Topical Alternatives for Hair Loss: Beyond the Conventional
- An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia
- The Impact of Growth Factors in Platelet‐Rich Plasma Combination Therapy for Androgenic Alopecia
- Efficacy and safety of microneedling radiofrequency in patterned hair loss
- Evaluation of Anxiety and Depression in Patients with Androgenetic Alopecia in Shanghai: A Cross-Sectional Study
- The therapeutic, diagnostic, and prognostic values of extracellular vesicles (exosomes) in dermatology: A systematic review
- Effect of iontophoresis with growth factor cocktail containing fibroblast growth factor 5-short applied to the scalp in patients with androgenetic alopecia – A split study
- Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients
- Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects
- Hair Number per Follicular Unit as a Marker of Treatment Response to Combined Autologous Scalp‐Derived Micrografts and Allogeneic SHED ‐ CM in Male Androgenetic Alopecia
- Additive Effects of Platelet-Rich Plasma and Systemic Therapies in Androgenetic Alopecia: A Retrospective Study
- Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study
- Autolougous platelet concentrates in esthetic medicine
- Oral Supplementation with l-Cystine, <i>Serenoa repens</i>, <i>Cucurbita pepo</i>, and <i>Pygeum africanum</i> in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study
- Topical cetirizine for the management of androgenic alopecia: Results of a pilot study
- Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature
- Dermatologic care for lesbian, gay, bisexual, and transgender persons